Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women
- 1 December 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (18) , 2313-2316
- https://doi.org/10.1016/s0959-8049(00)00306-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populationsAtherosclerosis, 1998
- Analysis of the 677 C→T Mutation of the Methylenetetrahydrofolate Reductase Gene in Different Ethnic GroupsThrombosis and Haemostasis, 1998
- Germ line polymorphisms in cytochrome-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibilityCarcinogenesis: Integrative Cancer Research, 1997
- Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomasBritish Journal of Cancer, 1997
- Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesisClinical Chemistry, 1997
- High Frequency of BRCA1 185delAG Mutation in Ovarian Cancer in IsraelPublished by American Medical Association (AMA) ,1996
- Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer familiesNature Medicine, 1996
- Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancerNature Genetics, 1996
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995